Republicans in the US Senate have said they will spare the US-backed HIV/Aids programme Pepfar from cuts, amid a larger effort to reduce government spending. Senators said they would end a plan to cut $400m (£300m) from the President's Emergency Plan for Aids Relief programme, leaving total proposed cuts at $9bn.

Prior to a procedural vote Tuesday to begin debate on the $9.4 billion package, Office of Management and Budget (OMB) Director Russell Vought said that the White House had agreed to an amendment to the bill that would exempt the HIV/AIDS relief program.

In his rescissions request to Congress last month, President Donald Trump asked that the hundreds of millions dollars budgeted for the President's Emergency Plans for AIDS Relief, or PEPFAR, be cancelled.

The US Senate votes to keep money for the President’s Emergency Plan for Aids Relief from a package of more than $9 billion in cuts going through Congress

House Republicans late Thursday night approved the first batch of cuts made by the Department of Government Efficiency (DOGE), sending the $9 billion package to President Trump’s desk in a big

Senate Republicans advance President Donald Trump's $9 billion spending clawback package through final procedural hurdle, with some bipartisan opposition to foreign aid cuts.

The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government says it has saved the lives of over 25 million people around the world with HIV.

The proposed cuts have caused concerns among some Senate Republicans, including Utah Sen. John Curtis, who may consider removing that provision from the final package.

The Trump administration agreed to exempt a global AIDS-relief program from spending cuts in the rescissions package.

Vice President Vance on Tuesday night broke a tie to allow the Senate to begin debate on a bill to claw back billions of dollars in funding previously authorized by Congress for foreign aid and

This development offers hope to millions of people living with HIV/AIDS in Nigeria and other developing countries.